MedPath

INQOVI

INQOVI

Approved
DIN Number

02501600

Drug Class

Human

Market Date

Nov 11, 2020

Company
HC

taiho pharma canada, inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02501600
AIG Number0262355001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01BC58 DECITABINE, COMBINATIONS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

CEDAZURIDINEActive
Strength: 100 MG
Monograph: CEDAZURIDINE
DECITABINEActive
Strength: 35 MG
Monograph: DECITABINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.